imipenem, anhydrous has been researched along with Muscular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daikos, GL; Loli, A; Miriagou, V; Panagiotakopoulou, A; Tzelepi, E; Tzouvelekis, LS | 1 |
| Ardanuy, C; Carratalá, J; Fernández-Sevilla, A; González-Barca, E; Grañena, A; Sanchez, A | 1 |
| Guiot, HF; Mattie, H; van Furth, R; van Ogtrop, ML | 1 |
3 other study(ies) available for imipenem, anhydrous and Muscular Diseases
| Article | Year |
|---|---|
Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Dose-Response Relationship, Drug; Female; Imipenem; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscular Diseases; Neutropenia; Time Factors | 2007 |
Fatal myofascial necrosis due to imipenem-resistant Aeromonas hydrophila.
Topics: Adult; Aeromonas hydrophila; Amikacin; Anemia, Aplastic; Anti-Bacterial Agents; Drug Resistance, Microbial; Fatal Outcome; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Male; Muscular Diseases; Necrosis; Thienamycins; Thigh | 1997 |
Relation between the therapeutic efficacy of imipenem in an experimental infection in granulocytopenic mice and its effect on murine intestinal microbial ecology.
Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Colony Count, Microbial; Drug Combinations; Escherichia coli Infections; Imipenem; Injections, Subcutaneous; Intestines; Male; Mice; Muscular Diseases; Specific Pathogen-Free Organisms; Thigh | 1990 |